Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis

BACKGROUND The clinical efficacy and safety of combination therapy with acetylcholinesterase inhibitor (AChEI) and memantine compared to AChEI or memantine alone in patients with Alzheimer’s disease is inconclusive. AIMS OF THE STUDY. We conducted a systematic review and meta...

Full description

Bibliographic Details
Main Authors: Dominik Glinz, Viktoria L. Gloy, Andreas U. Monsch, Reto W. Kressig, Chandni Patel, Kimberly Alba McCord, Zanfina Ademi, Yuki Tomonaga, Matthias Schwenkglenks, Heiner C. Bucher, Heike Raatz
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2019-06-01
Series:Swiss Medical Weekly
Subjects:
Alzheimer’s
cholinesterase inhibitor
dementia
drug treatment
memantine
Online Access:https://www.smw.ch/index.php/smw/article/view/2635

Internet

https://www.smw.ch/index.php/smw/article/view/2635

Similar Items